Abstract Candidiasis (eg, oral, gastrointestinal, vaginal, urinary tract, systemic) is a
worldwide growing problem, since antifungal resistance and immunosuppression states are …

Fungal burden throughout the world is very high and it keeps escalating due to increasing
numbers of immunocompromised individuals. In contrast, the drugs used in management of …

Dermatologists commonly prescribe medications such as antibiotics and corticosteroids that
can increase the risk for candidiasis. Though conventional antifungals are often effective …

Candida is an opportunistic pathogen that causes mucosal and deep systemic candidiasis.
The emergence of drug resistance and the side effects of currently available antifungals …

Candida is a major human fungal pathogen causing infectious conditions predominantly in
the elderly and immunocompromised hosts. Although Candida resides as a member of the …

Due to the high incidence of fungal infections caused by Candida species and their
increasing resistance to antimicrobial treatments, alternative therapies such as probiotics …

Oropharyngeal Candidiasis (OPC) is a mucosal fungal infection that is prevalent among
patients with compromised immunity. The success of probiotics in treating chronic diseases …

The extensive use of immunosuppressive therapies in recent years has increased the
number of patients prone to or actually suffering from localised candidosis. As Candida …

1University of Wisconsin Medical School, Departments of Surgery and Medical Microbiology
and Immunology, Madison, WI 53706-1532 and 2National Center for Toxicological …

The global infection rate of fungal diseases is increasing year by year, and it has gradually
become one of the most serious infectious diseases threatening human health. However …